Approaches to the formation of the project for the National drug policy. Part II. National drug policy as a strategical paper. Part III. Assessment of the financing needs for the necessary amounts of the outpatient pharmaceutical consumption and range of drugs for the next 2-5 years and for the development of new drugs in the Russian Federation for the future 10 years

• Guzel E. Ulumbekova
• Kalashnikova Aleksandra V.
• Akhmetova Guzel M.

Abstract

Higher School for Healthcare Organization and Management (VSHOUZ) continues the cycle of articles devoted to the issues of scientific foundation of National drug (pharmaceutical) policy. Part 2 describes the concepts and definitions of the National drug policy, its goals and objectives, content and interdepartmental approach for development. In part 3 were assessed the needs for the necessary amounts of financing and outpatient pharmaceutical provision of the population of the Russian Federation for the next 2-5 years, also was presented the classification of diseases for which it's necessary to compensate the population's costs for drugs in the first place, were considered the methods for calculating the required volumes of pharmaceuticals. The required financing is additionally 330 billions of rubles annually in the prices of the year 2017. Basing on comparison with developed countries, were made calculations of the necessary investments for the development of 30 innovative drugs in the Russian Federation for the future 10 years, were suggested approaches to the management of this process. Based on the analysis, it is shown that additional scientific researches are required for the resolution of National drug policy.

Keywords:national drug policy, strategic planning, pharmaceutical (drug) provision of the population, needs for pharmaceutical (drug) provision, calculations of needs for drugs, trends in the pharmaceutical industry development, innovative pharmaceuticals (drugs)

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)